Align Technology Funds Research Grants to Universities Worldwide for Advancing Orthodontic and Dental Research

$275,000 in Research Grants to be Funded as Part of its Ongoing Annual Research Awards Program

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of eleven research grants to universities under the company’s thirteenth Annual Research Award Program.

“Align is committed to the advancement of the orthodontic and dental fields and we are pleased to support university research around the world, said Dr. Mitra Derakhshan, Align senior vice president, global clinical. “We are excited to see the findings and future clinical insights about Invisalign® clear aligner treatment and its applicability for a broad range of clinical case types for patients of all ages. Continued research around all aspects of clear aligner treatment will increase awareness within the dental community about the efficacy of clear aligner treatment as compared to traditional appliances.”

The Americas research award recipients for 2023 are:

University of Washington (Seattle, US) – Primary Investigator, Dr. Greg Huang

University of the Pacific (San Francisco, US) – Primary Investigator, Dr. Heeyeon Suh

University of Alberta (Edmonton, Alberta, Canada) – Primary Investigator, Dr. Camila Pacheco-Pereira

Uniderp (Campo Grande-MS, Brazil) – Primary Investigator, Dr. Paula Vanessa Peron Oltramari

The European research award recipients for 2023 are:

UniCamillus, International Medical University (Rome, Italy) – Primary Investigator, Dr. Roberta Lione

Mohammed Bin Rashid University (Dubai, United Arab Emirates) – Primary Investigator, Dr. Sabarinath Prasad

Johann Wolfgang Goethe University of Frankfurt (Frankfurt, Germany) – Primary Investigator, Dr. Babak Sayahpour

University of Milan (Milan, Italy) – Primary Investigator, Dr. Francesca Gaffuri

The Asia Pacific research award recipients for 2023 are:

Sichuan University (Chengdu, China) – Primary Investigator, Dr. Hu Long

School of Stomatology Wuhan University (Wuhan, China) – Primary Investigator, Dr. Sanjie Yeweng

Mahidol University (Bangkok, Thailand) – Primary Investigator, Dr. Narudol Treethanya

“Over the years, it has been rewarding to see the evolution of research projects and the results that have advanced understanding and awareness of the various approaches for the treatment of malocclusion,” said John Morton, Align vice president, technical fellow. “Align is proud to support these research studies that have directly impacted advancements in clear aligner treatment and provided the scientific information that doctors need to interpret the efficacy of Invisalign® clear aligner treatment.”

The 2023 funded research studies will cover a wide range of topics for projects seeking to better understand treatments in orthodontics and dentistry including, but not limited to: ClinCheck® treatment planning software and cone-beam computed tomography (“CBCT”) integration; Curve of Wilson in the lower arch using aligners vs. fixed appliances; comparing the pre-treatment characteristics, demographics, efficiency & effectiveness, prevalence and extent of white-spot-lesions in adolescents treated with aligners vs. fixed appliances in an academic setting; comparing the maxillary and mandibular arch changes with aligners vs. removable palatal expansion and Schwarz appliances; evaluating the treatment outcomes with clear aligner therapy during mixed dentition in transverse and vertical dimensions; comparing the microhardness values of the resin composite attachments using different light curing protocols; three-dimensional characteristics of facial soft tissues with Angle Class II malocclusion; clinical effectiveness of virtual root and bone model system; and, orofacial and smile changes with mandibular advancement, precision bite ramps, and craniofacial changes induced by maxillary expansion.

All award applications received were first reviewed and prioritized in a blind evaluation by an independent academic committee. The final recipients were then determined by Align Technology.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 243 thousand doctor customers and is key to accessing Align’s 500 million consumer market opportunity worldwide. Over the past 25 years, Align has helped doctors treat over 15.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Contacts

Align Technology
Madelyn Valente

Align Technology, Inc.

(909) 833-5839

[email protected]

Press Contact
Zeno Group

Sarah Johnson

(828) 551-4201

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.